Completed

Post-Polio Motor Neuron Disease: Clinical, Virological, and Immunological Studies

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Neuroinflammatory Diseases+21

+ Amyotrophic Lateral Sclerosis

+ Central Nervous System Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: June 1982
See protocol details

Summary

Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 1982

Actual date on which the first participant was enrolled.

"Post-polio syndrome" defines the new muscle weaknesses and the variety of new difficulties with daily living that some patients experience 25-35 years after maximum recovery from acute paralytic poliomyelitis. The new weakness appears to be due to disintegration of the distal nerve terminals of the surviving motor neurons whose soma has been stressed for years to maintain large motor units via excessive distal sprouting. The factors responsible for the disintegration of axonal sprouts and manifestation of the new weakness and fatigue are unknown. Whether an immune response to the poliovirus, immunogenetic, dysimmune or aging factors play a role in the pathogenesis of this process is also unknown. The purpose of this protocol is to apply specific neuromuscular, electrophysiological, histological, virological, and immunological tests to answer pertinent questions regarding the pathogenesis of the post-polio syndrome. Studied patients will undergo a series of clinical neuromuscular evaluations, quantitative muscle testing, electromyography including single fiber EMG, immunogenetic, viral and immunochemical studies in the serum and spinal fluid, muscle biopsy and swallowing evaluation. Although this is not a therapeutic study, the information obtained would help us understand the pathogenetic mechanisms of the new weakness and could help us design possible therapies.

Official TitlePost-Polio Motor Neuron Disease: Clinical, Virological, and Immunological Studies
NCT00001185
Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

360 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Neuroinflammatory DiseasesAmyotrophic Lateral SclerosisCentral Nervous System DiseasesCentral Nervous System InfectionsEnterovirus InfectionsInfectionsMetabolic DiseasesMuscular DiseasesMusculoskeletal DiseasesMyelitisNervous System DiseasesNeuromuscular DiseasesNutritional and Metabolic DiseasesPicornaviridae InfectionsPoliomyelitisRNA Virus InfectionsSpinal Cord DiseasesVirus DiseasesPostpoliomyelitis SyndromeMotor Neuron DiseaseNeurodegenerative DiseasesMuscular Disorders, AtrophicProteostasis DeficienciesTDP-43 Proteinopathies

Criteria

INCLUSION CRITERIA Patients with prior history of a well documented acute paralytic poliomyelitis with or without development of new neuromuscular symptoms after a minimum of 15 years from the acute illness will be studied. Patients will be screened in the outpatient clinic and will be studied as inpatients (or, if stable, as outpatients) for three day stay. Severly disabled patients with unstable respiratory function or those who require intensive care nursing or respiratory assistance will be excluded from the study.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, United StatesOpen National Institute of Neurological Disorders and Stroke (NINDS) in Google Maps
CompletedOne Study Center